Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.49)
# 3,540
Out of 5,127 analysts
177
Total ratings
46.67%
Success rate
-1.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $5.94 | +34.68% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $148.50 | +38.05% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $101.65 | +15.10% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $89.73 | +5.87% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $492.84 | +31.89% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $10.30 | +16.50% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $136.34 | -30.32% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $78.44 | +8.36% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $39.61 | -62.13% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $245.57 | +39.68% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.55 | +803.23% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $21.73 | +120.89% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $76.80 | +32.81% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $74.12 | -21.75% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $16.91 | +18.27% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $70.16 | +86.72% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $111.07 | +19.74% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $356.08 | -38.22% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $106.22 | +255.88% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $5.94
Upside: +34.68%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $148.50
Upside: +38.05%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $101.65
Upside: +15.10%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $89.73
Upside: +5.87%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $492.84
Upside: +31.89%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $10.30
Upside: +16.50%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $136.34
Upside: -30.32%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $78.44
Upside: +8.36%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $39.61
Upside: -62.13%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $245.57
Upside: +39.68%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.55
Upside: +803.23%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $21.73
Upside: +120.89%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $76.80
Upside: +32.81%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $74.12
Upside: -21.75%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $16.91
Upside: +18.27%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $70.16
Upside: +86.72%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $111.07
Upside: +19.74%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $356.08
Upside: -38.22%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $106.22
Upside: +255.88%